Development Of A Glucose-6-phosphate Dehydrogenase/ Haemoglobin Point-of-care Test For Malaria Elimination
Funder
National Health and Medical Research Council
Funding Amount
$560,608.00
Summary
Malaria elimination requires the use of specific anti-malarial drugs that treat the dormant malaria parasites in the liver. The use of these drugs in people with a deficiency of the glucose-6-phosphate dehydrogenase (G6PD) enzyme can lead to the catastrophic destruction of red blood cells and severe anaemia. There is a need for new G6PD diagnostic tests that can be delivered in remote, resource poor settings. This project will develop a G6PD point-of-care test to fast-track malaria elimination.
In Vitro Diagnostic For First Trimester Risk Assignment Of Gestational Diabetes
Funder
National Health and Medical Research Council
Funding Amount
$580,983.00
Summary
Pregnancy associated diabetes is a significant complication of pregnancy that has adverse health effects for both mother and baby. We have developed a multivariate algorithm to identify women during their first trimester of pregnancy who will subsequently develop gestational diabetes. The test requires further clinical validation to develop a commercial product and to implement it into clinical practice.
Skin Patch Technology For Fast And Simple Monitoring Of Disease
Funder
National Health and Medical Research Council
Funding Amount
$826,064.00
Summary
Micropatch kits will be developed to capture and detect disease-related biomarkers from the skin for diagnostic monitoring, without the need for needles, trained practitioners or expensive laboratory infrastructure